THE ROLE OF CRIPTO SIGNALING IN LETHAL PROSTATE CANCER

被引：0
|
作者：
Sousa, Elisa Rodrigues
Zoni, Eugenio
De Menna, Marta
Thalmann, George Niklaus
Kruithof-de Julio, Marianna
机构：
来源：
JOURNAL OF UROLOGY | 2021年 / 206卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD44-07
引用
收藏
页码：E739 / E739
页数：1
相关论文
共 50 条
  • [41] LETHAL PROSTATE CANCER IN THE PLCO CANCER SCREENING TRIAL
    Shoag, Jonathan
    Mittal, Sameer
    Halpem, Joshua
    Scherr, Douglas
    Hu, Jim
    Barbieri, Christopher
    JOURNAL OF UROLOGY, 2016, 195 (04): : E390 - E390
  • [42] Role of the cripto (EGF-CFC) family in embryogenesis and cancer
    Bianco, C
    Normanno, N
    Salomon, DS
    Ciardiello, F
    GROWTH FACTORS, 2004, 22 (03) : 133 - 139
  • [43] Focal Prostate Atrophic Lesions and Risk of Lethal Prostate Cancer
    Davidsson, S.
    Fiorentino, M.
    Andren, O.
    Fang, F.
    Mucci, L. A.
    Varenhorst, E.
    Fall, K.
    Stark, J. R.
    LABORATORY INVESTIGATION, 2011, 91 : 187A - 187A
  • [44] Re: Prostate Cancer Polygenic Risk Score and Prediction of Lethal Prostate Cancer
    Brookman-May, Sabine D.
    May, Matthias
    EUROPEAN UROLOGY, 2023, 83 (05)
  • [45] Helping to address the over treatment of prostate cancer: tools to differentiate lethal and non-lethal phenotype in prostate cancer
    Getzenberg, Robert H.
    Carter, H. Ballentine
    ASIAN JOURNAL OF ANDROLOGY, 2012, 14 (03) : 347 - 348
  • [46] Tumor clone dynamics in lethal prostate cancer
    da Silva, Fernando Calais
    Oliveira, Pedro
    EUROPEAN UROLOGY, 2017, 71 (01) : 142 - 143
  • [47] The evolutionary history of lethal metastatic prostate cancer
    Gundem, Gunes
    Van Loo, Peter
    Kremeyer, Barbara
    Alexandrov, Ludmil B.
    Tubio, Jose M. C.
    Papaemmanuil, Elli
    Brewer, Daniel S.
    Kallio, Heini
    Hognas, Gunilla
    Annala, Math
    Kivinummi, Kati
    Goody, Victoria
    Latimer, Calli
    O'Meara, Sarah
    Dawson, Kevin J.
    Isaacs, William
    Emmert-Buck, Michael R.
    Nykter, Matti
    Foster, Christopher
    Kote-Jarai, Zsofia
    Easton, Douglas
    Whitaker, Hayley C.
    Neal, David E.
    Cooper, Colin S.
    Eeles, Rosalind A.
    Visakorpi, Tapio
    Campbell, Peter J.
    McDermott, Ultan
    Wedge, David C.
    Bova, G. S.
    CANCER RESEARCH, 2015, 75
  • [48] Immunotherapy for Prostate Cancer: Treatments for the "Lethal" Phenotype
    Slovin, Susan F.
    UROLOGIC CLINICS OF NORTH AMERICA, 2020, 47 (04) : 469 - 474
  • [49] Contemporary management of prostate cancer with lethal potential
    Davis, John W.
    Shaves, Mark E.
    Schellhammer, Paul F.
    ONCOLOGY-NEW YORK, 2004, 18 (07): : 811 - 820
  • [50] The Lethal Clone in Prostate Cancer: Redefining the Index
    Barbieri, Christopher E.
    Demichelis, Francesca
    Rubin, Mark A.
    EUROPEAN UROLOGY, 2014, 66 (03) : 395 - 397
12345